Regxia is a regulatory consulting firm serving the pharma & biotech industries. Founded in 2007, Regxia is experienced in compiling and e-publishing compliant dossers for submission to the FDA and Health Canada. Regxia’s services also include conducting reviews of promotional and medical materials; XML PM creation; regulatory strategy; medical writing; and Canadian QA and PV activities.